• CPI-613 and Mitochondrial Cell-Death Assays

  2026-09-23

  Explore how CPI-613 can probe mitochondrial carbon metabolism—and how to distinguish its established metabolic effects from hypotheses about ferroptosis. This assay-focused guide connects PDH and KGDH inhibition with practical, cautious interpretation of cancer-cell death readouts.

• SIRT1/2 Inhibitor IV (cambinol) in Cell Assays

  2026-09-23

  Learn how SIRT1/2 Inhibitor IV (cambinol), SKU B6063, can support controlled viability, proliferation, acetylation, hypoxia, and apoptosis experiments. This scenario-based guide separates published evidence from practical assay design recommendations for more interpretable cell-based data.

• Miltefosine Activates ERK to Restore Neutrophils

  2026-09-22

  The reference study identifies Miltefosine as a potential leukopenia intervention that promotes neutrophil differentiation through Ras/MEK/ERK signaling. By combining leukemia-cell assays, an irradiation-induced mouse model, transcriptomics, network pharmacology, docking, and pathway inhibition, the work connects functional neutrophil recovery with ERK-dependent mechanism while highlighting important translational limits.

• Moxidectin–Polyenes Synergy in Oral Candidiasis

  2026-09-22

  A 2024 study shows that moxidectin increases ergosterol biosynthesis in Candida albicans, thereby strengthening the activity of amphotericin B and Nystatin against planktonic growth, biofilms, and oral infection in mice. The work provides a mechanistically supported potentiation strategy, while also highlighting the need to resolve formulation, safety, resistance, and clinical-translation questions before human application.

• LNP–mRNA Vaccination Against Chlamydia psittaci

  2026-09-21

  Wang and colleagues developed a lipid nanoparticle-delivered, non-replicating mRNA vaccine encoding the major outer membrane protein of Chlamydia psittaci and evaluated its expression, immunogenicity, and protective activity in BALB/c mice. The study links MOMP expression with reduced pulmonary bacterial burden, shedding, and inflammatory cytokines, while also defining practical quality-control steps for preclinical mRNA vaccine development.

• EGFP mRNA m1Ψ: A Mechanistic Assay Framework

  2026-09-21

  EGFP mRNA m1Ψ can do more than report transfection: it can help separate delivery, translation, RNA stability, and cell-state effects. This article develops a causal assay framework for interpreting N1-methylpseudouridine EGFP mRNA experiments and connects it to recent cap-independent translation research.

• Clathrin-Mediated Entry of Type III Grass Carp Reovirus

  2026-09-20

  Wang et al. used pharmacological inhibitors, transmission electron microscopy, and real-time quantitative PCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, acidified clathrin-mediated endocytic route. The study provides a pathway-level framework for distinguishing viral entry mechanisms while highlighting the limits of interpreting inhibitor data as definitive molecular proof.

• AG-120 (Ivosidenib): From 2-HG to AML Biology

  2026-09-19

  AG-120 (Ivosidenib) is more than a mutant IDH1 inhibitor: it is a tool for connecting 2-hydroxyglutarate reduction with differentiation, metabolic state, and assay interpretation. This article examines how CD44-dependent NADPH rewiring changes the way researchers evaluate AML mutant IDH1 treatment.

• Indole-3-pyruvic acid: Applied Research Workflows

  2026-09-18

  Indole-3-pyruvic acid connects auxin biosynthesis, fungal metabolism, and AhR-focused immune studies in one experimentally tractable metabolite. This guide converts pathway biology into practical workflows for flux analysis, PBMC assays, and troubleshooting, while separating established findings from optimization proposals.

• WNT5a/GSK3/β-Catenin Controls FAP Adipogenesis

  2026-09-18

  The reference study identifies the WNT5a/GSK3/β-catenin axis as a regulatory pathway that restrains adipogenic conversion of skeletal muscle fibro/adipogenic progenitors. By combining pharmacological inhibition, mass cytometry, animal models, network analysis, and transcriptomics, it connects FAP fate decisions with muscle regeneration and pathological fat accumulation.

• Oseltamivir acid: Reliable Assay Workflows

  2026-09-17

  This scenario-based guide explains how Oseltamivir acid (SKU A3689) can support reproducible influenza antiviral research and exploratory cell-viability studies. It covers mechanism, formulation, protocol controls, resistance interpretation, translational limitations, and practical supplier-selection criteria.

• CRL3ARMC5 and Integrator Control RNA Pol II

  2026-09-17

  Cacioppo et al. identify CRL3ARMC5 ubiquitin ligase and the Integrator complex as parallel quality-control pathways that regulate RNA polymerase II before productive elongation. Their findings show that RNA Pol II abundance alone is insufficient: cells must also prevent defective transcription complexes from entering gene bodies.

• Vacuolin-1: Lysosomal Exocytosis Inhibitor

  2026-09-16

  Vacuolin-1 is a cell-permeable lysosomal exocytosis inhibitor that blocks Ca2+-dependent lysosome–plasma membrane fusion. It provides a practical perturbation tool for lysosomal β-hexosaminidase release assays, membrane repair research, and studies of lysosome-mediated trafficking.

• Nystatin (Fungicidin) Research Workflows

  2026-09-16

  Build reproducible Candida susceptibility, adhesion, and membrane-perturbation assays with Nystatin (Fungicidin), while controlling the solubility and vehicle variables that can obscure polyene activity. The workflow also uses a Spiroplasma S2-cell study to show when Nystatin is informative as a negative pathway control rather than an antifungal treatment.

• TRIM66 and the One-Receptor Rule in Olfactory Neurons

  2026-09-15

  The reference study identifies TRIM66 as an epigenetic repressor that helps mature olfactory sensory neurons silence all but one olfactory receptor gene. Its loss preserves low-level expression of multiple receptors, disrupts olfactory neural activity, and impairs innate olfactory behaviors, linking enhancer repression to sensory circuit function.

8620 records 1/575 page Next 12345 下5页 Last page